Mitchell Shultz, MD
Show Description +
Mitchell Shultz, MD, shares results of a post-hoc analysis from the Saturn 2 trials exploring treatment of Demodex Blepharitis. Dr. Shultz is hopeful that this treatment will have a positive impact on patients suffering with Demodex Blepharitis.
Posted: 11/16/2023
Mitchell Shultz, MD
Mitchell Shultz, MD, shares results of a post-hoc analysis from the Saturn 2 trials exploring treatment of Demodex Blepharitis. Dr. Shultz is hopeful that this treatment will have a positive impact on patients suffering with Demodex Blepharitis.
Posted: 11/16/2023
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AAO: 2023.
Please log in to leave a comment.